@article{e419c5fb3a2f4c31903689e6b3cddd77,
title = "Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary Fibrosis. Reply",
keywords = "Cyclic Nucleotide Phosphodiesterases, Type 4, Humans, Idiopathic Pulmonary Fibrosis, Phosphodiesterase 4 Inhibitors, Cyclic Nucleotide Phosphodiesterases, Type 4, Humans, Idiopathic Pulmonary Fibrosis, Phosphodiesterase 4 Inhibitors",
author = "Luca Richeldi and Susanne Stowasser and Maher, {Toby M}",
year = "2022",
doi = "10.1056/NEJMc2209529",
language = "English",
volume = "387",
pages = "762--762",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society:860 Winter Street:Waltham, MA 02451:(800)843-6356, (781)893-3800, EMAIL:
[email protected], INTERNET: http://www.massmed.org/, Fax: (781)647-5785, (781)893-7368",
}